Abstract

Since the COVID-19 pandemic outbreak, the development of vaccines for passive immunization against SARS-CoV-2 has been a great scientific achievement. However, all these vaccines have been rarely related to neurological adverse events. We present an extremely rare case of a 39-year-old healthy male adult who developed an immune-mediated adverse event of a small fiber neuropathy and radiculopathy post-anti-COVID vaccination with Oxford-Astra Zeneca Covid-19 vaccine. Despite this rare adverse event, we underline that both at an individual and a population level, the benefits of COVID-19 vaccination far outweigh the risks of a neurological complication.

Keywords: Small Fiber; Neuropathy; Covid-19; Intrathecal

References

1. Waheed W., et al. “Post COVID-19 vaccine small fiber neuropathy”. Muscle Nerve1 (2021): E1-E2.
2. Goss AL., et al. “ANA Investigates: Neurological Complications of COVID-19 Vaccines”. Annals of Neurology 89 (2021): 856-857.
3. Kim DD., et al. “Helping the Public Understand Adverse Events Associated with COVID-19 Vaccinations: Lessons Learned from Functional Neurological Disorder”. JAMA Neurology 7 (2021): 789-790.
4. Devigili G., et al. “Clinical diagnosis and management of small fiber neuropathy: an update on best practice”. Expert Review of Neurotherapeutics 9 (2020): 967-980.
5. Raasing LRM., et al. “Current View of Diagnosing Small Fiber Neuropathy”. Journal of Neuromuscular Diseases2 (2021): 185-207.
6. Vecchio M., et al. “A systematic review of pharmacologic and rehabilitative treatment of small fiber neuropathies”. Diagnostics12 (2020).
7. Souayah N., et al. “Small fiber neuropathy following vaccination for rabies, varicella or Lyme disease”. Vaccine52 (2009): 7322-7325.
8. Liu X., et al. “IVIg for apparently autoimmune small-fiber polyneuropathy: First analysis of efficacy and safety”. Therapeutic Advances in Neurological Disorders 11 (2018): 1-12.
9. Watad A., et al. “Immune-mediated disease flares or new-onset disease in 27 subjects following mrna/dna sars-cov-2 vaccination”. Vaccines5 (2021): 1-23.
10. Lu L., et al. “The potential neurological effect of the COVID-19 vaccines: A review”. Acta Neurologica Scandinavica1 (2021): 3-12.
11. Finsterer J and Scorza FA. SARS-CoV-2 vaccines are not free of neurological side effects”. Acta Neurologica Scandinavica 1 (2021): 109-110.
12. Summary of Product Characteristics for Vaxzevria - GOV.UK (2021).
13. Vaccine Adverse Event Reporting System (VAERS).
14. Scheel DP. “Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19”. Annals of Oncology (2020): 19-20.
15. Kow CS and Hasan SS. “Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies”. Inflammopharmacology 4 (2021): 1075.

Citation

Citation: Anthoula Tsolaki., et al. “Small Fiber Neuropathy and Intrathecal Presence of IgG Oligoclonal Bands Post- Vaccination with Oxford-AstraZeneca Covid-19 Vaccine". Acta Scientific Neurology 5.5 (2022): 20-25.

Copyright

Copyright: © 2022 Anthoula Tsolaki., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.